Health & WellnessBristol Myers Cancer Therapy RYZ101 Hits Phase 3 Goal: What Patients Should Know
Bristol Myers says investigational radiopharmaceutical RYZ101 met the main progression-free survival goal in the Phase 3 ACTION-1 trial, but detailed results and…